| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9909 | 
      | Human Intestinal Absorption | HIA- | 0.9895 | 
      | Caco-2 Permeability | Caco2- | 0.8304 | 
      | P-glycoprotein Substrate | Substrate | 0.6689 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9162 | 
                                                     | Non-inhibitor | 0.9974 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9571 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.5684 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8432 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8214 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5000 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8868 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9069 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9253 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8939 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8408 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9860 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9995 | 
                                                                    | Non-inhibitor | 0.9066 | 
      | AMES Toxicity | Non AMES toxic | 0.8601 | 
      | Carcinogens | Non-carcinogens | 0.8387 | 
      | Fish Toxicity | High FHMT | 0.7253 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.5405 | 
      | Honey Bee Toxicity | Low HBT | 0.7209 | 
      | Biodegradation | Not ready biodegradable | 0.9571 | 
      | Acute Oral Toxicity | IV | 0.4954 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6422 |